SREBF2 and Sepsis: Further, these authors utilized a murine model to test whether inhibiting SREBP-2 impacted sepsis outcomes and demonstrated that blocking SREBP-2 activation helped suppress cytokine storm, pulmonary damage, and promoted high survival rates (46).